SEC Form 4 · accession 0001437749-18-011838
BIOLIFE SOLUTIONS INC · BLFS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew G Hinson
Director
Period of report
Jun 13, 2018
Accepted (ET)
Jun 14, 2018 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000834365
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 13, 2018 | M | 10,714 | $1.261 | A | 49,033 | D | |
| Common Stock | Jun 13, 2018 | M | 10,714 | $1.401 | A | 59,747 | D | |
| Common StockF1 | Jun 13, 2018 | S | 10,000 | $11.25 | D | 49,474 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option | $1.261 | Jun 13, 2018 | M | 10,714 | D | Feb 27, 2010 | Feb 26, 2019 | Common Stock | 10,714 | 0 | D |
| Employee Stock Option | $1.401 | Jun 13, 2018 | M | 10,714 | D | Feb 5, 2011 | Feb 4, 2020 | Common Stock | 10,714 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.10 to $11.40, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.